Guillain-Barré syndrome

Lancet Neurol. 2008 Dec;7(12):1081-2; author reply 1083-5. doi: 10.1016/S1474-4422(08)70248-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenal Cortex Hormones / pharmacology
  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Drug Administration Schedule
  • Guillain-Barre Syndrome / therapy*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Inflammation Mediators / antagonists & inhibitors
  • Outcome Assessment, Health Care / methods
  • Plasmapheresis / standards
  • Randomized Controlled Trials as Topic / methods*
  • Randomized Controlled Trials as Topic / standards

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Immunoglobulins, Intravenous
  • Inflammation Mediators